AbCellera Biologics Inc. (ABCL) Social Stream



AbCellera Biologics Inc. (ABCL): $7.57

0.18 (+2.44%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ABCL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ABCELLERA BIOLOGICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $55 $25 $45.25 $7.42 509.84%
2021-12-05 5 $53 $25 $40.8 $7.42 449.87%
2021-12-19 7 $53 $25 $39.833 $7.42 436.83%
2021-12-21 7 $45 $25 $33 $7.42 344.74%
2022-02-11 5 $45 $25 $33 $7.42 344.74%
2022-02-25 5 $40 $20 $30 $7.42 304.31%
2022-05-09 5 $40 $20 $29.6 $7.42 298.92%
2022-05-11 5 $32 $14 $24.8 $7.42 234.23%
2022-08-09 5 $32 $14 $23.6 $7.42 218.06%
2022-08-11 5 $34 $14 $24 $7.42 223.45%
2022-10-23 5 $34 $13 $23.8 $7.42 220.75%
2022-11-02 4 $34 $13 $23.6 $7.42 218.06%
2022-11-09 5 $32 $20 $23.6 $7.42 218.06%
2022-11-30 6 $32 $20 $24.5 $7.42 230.19%
2022-12-15 6 $32 $20 $25.285 $7.42 240.77%
2023-01-06 6 $32 $18 $25 $7.42 236.93%
2023-02-21 7 $32 $18 $25 $7.42 236.93%
2023-02-22 7 $32 $18 $25.5 $7.42 243.67%

The Trend in the Analyst Price Target


ABCL's average price target has moved down $15.3 over the prior 15 months.

ABCL reports an average of 166.04% for its upside potential over the past 45 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-26 5 32 14 23.600 10.19 131.6%
2022-08-09 5 32 14 23.600 11.11 112.42%
2022-11-16 6 32 20 24.500 14.52 68.73%
2022-12-15 6 32 20 25.285 10.40 143.12%
2023-02-21 7 32 18 25.000 8.89 181.21%

ABCL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


ABCL's average broker recommendation rating improved by 0 over the prior 31 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, ABCELLERA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is greater than 2366.69% of them.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, ABCELLERA BIOLOGICS INC's number of analysts covering the stock is greater than 202.59% of them.
  • ABCELLERA BIOLOGICS INC's average analyst price target is greater than 428.1% of stocks in the large market cap category.
  • ABCELLERA BIOLOGICS INC's variance in analysts' estimates is lower than -1851.64% of stocks in the large market cap category.

In the Pharmaceutical Products industry, RVMD, BEAM, and VIR are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ABCL using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6094 seconds.